Repro Med Systems Accounts Payables 2011-2026 | KRMD

Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.

Main types of accounts payable

Type of liability	Example
To suppliers and contractors	Goods received but not yet paid for
Taxes and fees	VAT, income tax, etc., not paid on time
Salaries	Employee wages not paid
To budgets	Insurance contributions to funds not paid
To founders	Founders provided borrowed funds
To banks	Overdue loan payments
Other	Fines, penalties, forfeits, customer prepayments, etc.

Impact on the company's financial performance

Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios
Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence
Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals)
Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated

Annual Accounts Payables Repro Med Systems

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.27 M	1.65 M	975 K	2.39 M	1.23 M	625 K	573 K	453 K	454 K	308 K	243 K	247 K	110 K	200 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.39 M	110 K	837 K

Quarterly Accounts Payables Repro Med Systems

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.87 M	1.09 M	2.01 M	1.65 M	1.67 M	1.6 M	1.77 M	975 K	946 K	1.57 M	1.5 M	2.39 M	1.37 M	-	1.27 M	1.23 M	1.39 M	1.01 M	1.92 M	625 K	625 K	625 K	625 K	573 K	573 K	573 K	573 K	453 K	453 K	453 K	453 K	454 K	454 K	454 K	454 K	911 K	710 K	608 K	308 K	522 K	310 K	397 K	243 K	679 K	432 K	520 K	247 K	206 K	249 K	197 K	110 K	203 K	113 K	227 K	200 K	310 K	172 K	-	158 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.39 M	110 K	766 K

Accounts Payables of other stocks in the Medical instruments industry

Issuer	Accounts Payables	Price	% 24h	Market Cap	Country
Baxter International BAX	999 M	$ 16.61	-0.27 %	$ 8.52 B	USA
electroCore ECOR	2.71 M	$ 6.83	-3.05 %	$ 57.9 K	USA
Ekso Bionics Holdings EKSO	1.43 M	$ 9.06	-7.08 %	$ 22 M	USA
Atrion Corporation ATRI	6.63 K	-	-	$ 810 M	USA
Glaukos Corporation GKOS	13.4 M	$ 116.47	-0.19 %	$ 5.64 B	USA
Haemonetics Corporation HAE	67 M	$ 58.88	0.72 %	$ 2.96 B	USA
Harvard Bioscience HBIO	3.65 M	$ 5.39	-2.53 %	$ 239 M	USA
iRhythm Technologies IRTC	2.26 M	$ 116.86	-0.31 %	$ 3.74 B	USA
Masimo Corporation MASI	253 M	$ 178.4	-0.05 %	$ 9.51 B	USA
Microbot Medical MBOT	511 K	$ 2.31	-2.33 %	$ 106 M	Israel
Milestone Scientific MLSS	780 K	$ 0.29	1.52 %	$ 23.8 M	USA
Envista Holdings Corporation NVST	192 M	$ 25.24	-2.21 %	$ 4.24 B	USA
The Cooper Companies COO	300 M	$ 69.68	-0.87 %	$ 13.9 B	USA
Pro-Dex PDEX	4.61 M	$ 49.01	0.99 %	$ 161 M	USA
ResMed RMD	159 M	$ 224.23	-0.31 %	$ 32.8 B	USA
Retractable Technologies RVP	5.34 M	$ 0.69	-2.42 %	$ 20.7 M	USA
STAAR Surgical Company STAA	11.6 M	$ 21.32	1.72 %	$ 1.06 B	USA
Stereotaxis STXS	4.77 M	$ 1.84	-2.13 %	$ 167 M	USA
Teleflex Incorporated TFX	130 M	$ 115.47	0.37 %	$ 5.15 B	USA
Utah Medical Products UTMD	911 K	$ 63.75	1.3 %	$ 207 M	USA
BioLife Solutions BLFS	3.57 M	$ 18.77	-2.59 %	$ 865 M	USA
AtriCure ATRC	25.3 M	$ 29.25	0.21 %	$ 1.4 B	USA
West Pharmaceutical Services WST	254 M	$ 258.56	0.67 %	$ 18.7 B	USA
ICU Medical ICUI	154 M	$ 121.92	-0.87 %	$ 3 B	USA
InfuSystem Holdings INFU	8.34 M	$ 9.49	0.58 %	$ 196 M	USA
Intuitive Surgical ISRG	255 M	$ 451.55	-0.23 %	$ 161 B	USA
LeMaitre Vascular LMAT	3.65 M	$ 109.61	0.41 %	$ 2.48 B	USA
Merit Medical Systems MMSI	60.6 M	$ 67.62	-0.28 %	$ 4 B	USA
Predictive Oncology POAI	1.84 M	-	-	$ 31.1 M	USA
Pulse Biosciences PLSE	2.78 M	$ 20.31	-11.49 %	$ 1.37 B	USA
DENTSPLY SIRONA XRAY	300 M	$ 11.56	-0.69 %	$ 2.31 B	USA
NeuroMetrix NURO	363 K	-	5.05 %	$ 9.02 M	USA
STERIS plc STE	281 M	$ 219.29	-0.31 %	$ 21.6 B	USA
AngioDynamics ANGO	33.3 M	$ 9.58	-2.64 %	$ 391 M	USA
Becton, Dickinson and Company BDX	1.97 B	$ 154.54	-0.5 %	$ 44.5 B	USA
Nephros NEPH	873 K	$ 2.79	-2.45 %	$ 29 M	USA
OraSure Technologies OSUR	6.52 M	$ 3.02	-1.95 %	$ 222 M	USA
Repligen Corporation RGEN	19.6 M	$ 115.02	-1.65 %	$ 6.41 M	USA